SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 60 filers reported holding SUTRO BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,280,944 | -19.2% | 369,148 | +8.3% | 0.01% | -11.1% |
Q2 2023 | $1,585,594 | -20.6% | 340,988 | -21.1% | 0.01% | -30.8% |
Q1 2023 | $1,995,757 | -21.1% | 431,982 | +38.0% | 0.01% | -23.5% |
Q4 2022 | $2,528,886 | +79.1% | 312,981 | +23.1% | 0.02% | +70.0% |
Q3 2022 | $1,412,000 | +61.0% | 254,343 | +51.0% | 0.01% | +66.7% |
Q2 2022 | $877,000 | -10.4% | 168,390 | +41.4% | 0.01% | +20.0% |
Q1 2022 | $979,000 | -54.7% | 119,064 | -18.1% | 0.01% | -54.5% |
Q4 2021 | $2,163,000 | -25.7% | 145,351 | -5.7% | 0.01% | -31.2% |
Q3 2021 | $2,912,000 | +3.4% | 154,133 | +1.7% | 0.02% | +6.7% |
Q2 2021 | $2,817,000 | +84.0% | 151,520 | +125.3% | 0.02% | +66.7% |
Q1 2021 | $1,531,000 | +7.7% | 67,265 | +2.8% | 0.01% | +12.5% |
Q4 2020 | $1,421,000 | +246.6% | 65,452 | +60.3% | 0.01% | +166.7% |
Q3 2020 | $410,000 | +26.9% | 40,837 | -1.9% | 0.00% | +50.0% |
Q2 2020 | $323,000 | +42.3% | 41,626 | +86.8% | 0.00% | 0.0% |
Q1 2020 | $227,000 | +2737.5% | 22,282 | +3065.1% | 0.00% | – |
Q4 2019 | $8,000 | +33.3% | 704 | 0.0% | 0.00% | – |
Q3 2019 | $6,000 | -33.3% | 704 | -15.0% | 0.00% | – |
Q2 2019 | $9,000 | – | 828 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |